News
CVS stores are scheduled to open at former Rite Aid locations in Oregon between August and the end of September. Here are the ...
CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to ...
In 2014, Caremark was accused of manipulating how drug costs were reported, prompting Aetna and SilverScript to submit false ...
The store at 1515 W. State St. near downtown was planned to be sold to CVS Pharmacy as part of Rite Aid's bankruptcy ...
A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it ...
CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory ...
A federal judge has ordered CVS Caremark to pay almost $290 million in damages and penalties after a whistleblower proved the ...
A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...
3d
Investor's Business Daily on MSNCVS Health Stock Runs Hot Once Again, Hitting A New Buy Point
CVS Health stock offers an above-average dividend yield for investors seeking income and it's run up to a new buy point.
The owner of the U.S.' largest pharmacy benefit manager is declining to cover Gilead Sciences’ long-acting HIV prevention ...
The Gilead HIV prevention shot , called Yevtugo, is highly effective, but its list price is $28, 218 a year in the U.S.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results